• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Home
  • Pharma
    • Oncology
    • Vaccines
    • Asia
    • Cell & Gene Therapy
    • Drug Delivery
    • Executives
  • Manufacturing
    • Facilities
    • Recalls
    • Warning Letters
  • Marketing
  • Special Reports
  • Fierce 50
    • Special Report
    • Awards Gala
  • Trending
    • Supply Chain
    • AI and Machine Learning
  • Awards
    • Outsourcing Awards
    • Innovation Awards
    • AI Innovation Awards
    • Pharma Marketing Awards
  • Resources
    • Podcasts
    • Fierce Events
    • Industry Events
    • Webinars
    • Whitepapers
    • Survey
  • Events
  • Subscribe
Home
Subscribe
Hamburger Menu Hamburger Menu
  • Pharma
    • Oncology
    • Vaccines
    • Asia
    • Cell & Gene Therapy
    • Drug Delivery
    • Executives
  • Manufacturing
    • Facilities
    • Recalls
    • Warning Letters
  • Marketing
  • Special Reports
  • Fierce 50
    • Special Report
    • Awards Gala
  • Trending
    • Supply Chain
    • AI and Machine Learning
  • Awards
    • Outsourcing Awards
    • Innovation Awards
    • AI Innovation Awards
    • Pharma Marketing Awards
  • Resources
    • Podcasts
    • Fierce Events
    • Industry Events
    • Webinars
    • Whitepapers
    • Survey
  • Events
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us

Pharma

FDA
Manufacturing

FDA hands out 3 API warning letters after record request snubs

In a series of regulatory wrist-slaps now made public, the FDA has taken three manufacturers to task over record request breakdowns.
Fraiser Kansteiner Nov 11, 2026 4:20pm
Legend

Legend Biotech drops 16% as soft 2027 outlook tests new CEO

Nov 11, 2026 10:19am
Asking More of Science How Daiichi Sankyo Is Challenging Assumptions About the Future of Cancer Care

Asking More of Science: How Daiichi Sankyo Is Challenging Assumptions About the Future of Cancer Care

Brought to you by Daiichi Sankyo, Inc.
BioNTech

BioNTech pays $205M for FDA voucher to speed up cancer pipeline

Nov 11, 2026 8:20am
video
Why AIs Biggest Value in Pharma Is Confidence

Why AI’s Biggest Value in Pharma Is Confidence

Brought to you by /prompt
Stamp with blue ink that says FDA Approved

Merck KGaA's Pimjetmi wins FDA approval in rare tumor disorder

Nov 10, 2026 5:45pm
Home
  • Connect
    • The Team
    • Advertise
    • Marketing Kit
    • Let's Talk
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Biotech
    • Fierce Healthcare
    • Fierce Pharma
  • Our Events
    • Life Sciences Events
©2026 Questex LLC All rights reserved.
Terms of use
Privacy Policy
Privacy Settings